KCT0004952招募中未知
Investigations on the efficacy and safety of intradermal injection of botulinum toxin
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 23
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 30(Year) 至 59(Year)（—）
- 性别
- All
入选标准
- •1) Healthy adult men and women in their 30s and 50s
- •2) Those who can follow up during the clinical trial schedule (12 weeks)
- •3) Those who have no serious abnormalities in pre-examination or examination
- •4) A person who understands the consent before conducting all test-related evaluation / procedures, discloses the intention to participate in the clinical trial through himself or a legal representative, and signs the consent.
- •5) Those who can and willing to comply with the schedule of visits and other clinical trial protocol requirements.
排除标准
- •1) Those with systemic neuromuscular junction disorder
- •(Example: myasthenia gravis, Eaton-Lambert syndrome, amyotrophic lateral sclerosis, etc.)
- •2) Those who have the following treatment skills or who have plans during the clinical trial period that are thought to influence the evaluation of this clinical trial before the screening visit.
- •-Those who have undergone a permanent filler (silicone, fat grafting, tissue grafting, etc.) procedure that may affect wrinkle evaluation
- •-Those who have undergone a semi-permanent filler (CaHA (Calcium Hydroxyapatite), collagen-stimulator, etc.) procedure within 1 year prior to participation in clinical research
- •-Those who have undergone temporary filler (hyaluronic acid, etc.) treatment within 6 months of participation in clinical research
- •-Those who have undergone cosmetic procedures (radio-frequency treatment, HIFU, fractional laser, thread, chemical peeling over medium depth, etc.) on the face within 6 months of participation in clinical research
- •-In the case of using cosmetics, external preparations, or oral drugs with wrinkle improvement function, there has been a change in use from 1 month prior to the screening time, or is expected to change during the clinical trial participation period even if they are used stably.
- •3) People with facial asymmetry, skin relaxation, or deep scars on the face that interfere with wrinkles and texture evaluation, or those with excessively thick skin
- •4) Those who are allergic to a drug for clinical trials or its components or have a history of hypersensitivity reactions
- •5) Those who received botulinum toxin treatment within 3 months prior to the administration of the drug for clinical trials, or who intend to receive botulinum toxin treatment other than the clinical trial drug during the clinical trial period
- •6) Subjects who are prone to bleeding or who have taken anticoagulant drugs within 7 days prior to administration of the drug for clinical trials or who cannot stop the anticoagulant medication during the clinical trial period
- •7) People with skin abnormalities or infections at the site to be scanned
- •8) Those who have a history of drug and alcohol abuse and mental illness
- •9) Women who are pregnant, lactating, or whose pregnancy has been confirmed through pregnancy tests, or who do not agree to contraceptive through the methods allowed in this clinical trial during the period of participation in the clinical trial.
- •* All women of childbearing potential, except for women who have undergone amenorrhea or surgical infertility (bilateral tubal ligation, bilateral oophorectomy or hysterectomy) for at least 12 months, have a negative pregnancy test (urine) result prior to the start of the trial / control drug. Only if you can participate in a clinical trial. Medically acceptable methods of contraception include spermicide, oral contraceptives, intrauterine implants, and complete abstinence.
- •10) Participating in other clinical trials at the time of screening or participating in another clinical trial within 30 days of screening.
- •11) People who are taking drugs that interact with botulinum toxins
- •12) Those who cannot communicate or are unable to follow directions
- •13) Patients who are not suitable for this clinical trial at the discretion of other investigators
研究者
相似试验
招募中
不适用
evaluation of the efficacy and the safety of intralesional cidofovir for recurrent laryngeal papillomatosishuman papillomavirus positive recurrent laryngeal papillomatosisJPRN-UMIN000010967Department of Otorhinolaryngology, Head and Neck Surgery, Yokohama City University School of Medicine10
尚未招募
4 期
comparing the efficacy and safety ofintralesional acyclovir in two concentration in common wartsCTRI/2024/02/063057Dr RPGMC Kangra at Tanda
尚未招募
不适用
Safety and efficacy of Intrathecal Morphine as an Analgesic in Post-operative Total Knee ReplacementCTRI/2021/05/033462Dr Dipak Desai
招募中
不适用
Evaluation of efficiency and side effects of intrauterine insemination (IUI) catheter in infertile couplesFemale infertilityInfertility.IRCT20160703028756N5Esfahan University of Medical Sciences60
招募中
2 期
Comparison of intracoronary selected CD 133+ bone marrow stem cells in cardiac recovery after acute myocardial infarct and left ventricular dysfunction: COMPARE-AMI a randomized controlled double blind clinical studyHeart failureACTRN12609001045202Miltenyi Biotech Inc.40